TriSalus Life Sciences (TLSI) Earnings Date, Estimates & Call Transcripts $5.62 -0.10 (-1.73%) As of 03:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TriSalus Life Sciences Earnings Summary Upcoming Earnings DateMay. 21Before Market OpensEstimatedConsensus EPS (Mar. 27) -$0.35 Actual EPS (Mar. 27) -$0.35 Actual Revenue (Mar. 27) $8.26MTriSalus Life Sciences posted Q4 2024 earnings on March 27, 2025, reporting an EPS of -$0.35, which hit the consensus estimate of -$0.35. Quarterly revenue was reported to be $8.26 million, above the consensus estimate of $8.12 million. With a trailing EPS of -$1.33, TriSalus Life Sciences' earnings are expected to grow next year, from ($1.55) to ($0.61) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K)TLSI Upcoming EarningsTriSalus Life Sciences' Q1 2025 earnings is scheduled for Wednesday, May 21, 2025, with a conference call scheduled on Thursday, May 15, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get TriSalus Life Sciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TriSalus Life Sciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTLSI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TLSI Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. TriSalus Life Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.09-$0.09-$0.09Q2 20251-$0.11-$0.11-$0.11Q3 20251-$0.11-$0.11-$0.11Q4 20251-$0.09-$0.09-$0.09FY 20254($0.40)($0.40)($0.40) TriSalus Life Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/21/2025(Estimated)--------3/27/2025Q4 2024-$0.35-$0.35--$0.40$8.12M$8.26M8/14/2024Q2 2024--$0.21 -$0.21-$0.21-$7.36M5/15/2024Q1 2024--$0.54 -$0.54-$0.48-$6.46M4/1/2024Q4 2023--$1.56 -$1.56-$1.56-$5.72M11/14/2023Q3 2023--$0.13 -$0.13-$0.13-$5.19M TriSalus Life Sciences Earnings - Frequently Asked Questions When is TriSalus Life Sciences's earnings date? TriSalus Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 21st, 2025 based off last year's report dates. Learn more on TLSI's earnings history. What guidance has TriSalus Life Sciences issued on next quarter's earnings? TriSalus Life Sciences updated its FY 2025 earnings guidance on Thursday, March, 27th. The company issued revenue guidance of $44.1 million-, compared to the consensus revenue estimate of $44.8 million. Did TriSalus Life Sciences beat their earnings estimates last quarter? In the previous quarter, TriSalus Life Sciences (NASDAQ:TLSI) reported ($0.35) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.35). Learn more on analysts' earnings estimate vs. TLSI's actual earnings. How can I listen to TriSalus Life Sciences's earnings conference call? The conference call for TriSalus Life Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read TriSalus Life Sciences's conference call transcript? The conference call transcript for TriSalus Life Sciences's latest earnings report can be read online. Read Transcript How much revenue does TriSalus Life Sciences generate each year? TriSalus Life Sciences (NASDAQ:TLSI) has a recorded annual revenue of $29.43 million. How much profit does TriSalus Life Sciences generate each year? TriSalus Life Sciences (NASDAQ:TLSI) has a recorded net income of -$59.04 million. TLSI has generated -$1.33 earnings per share over the last four quarters. What is TriSalus Life Sciences's EPS forecast for next year? TriSalus Life Sciences's earnings are expected to grow from ($1.55) per share to ($0.61) per share in the next year. More Earnings Resources from MarketBeat Related Companies Iradimed Earnings Bioventus Earnings Butterfly Network Earnings Avanos Medical Earnings RxSight Earnings SI-BONE Earnings CeriBell Earnings OrthoPediatrics Earnings Beta Bionics Earnings Treace Medical Concepts Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsAmazon's Earnings Could Fuel a Rapid Breakout Tesla Earnings Miss, But Musk Refocuses and Bulls ReactQualcomm’s Range Narrows Ahead of Earnings as Bulls Step InWhy It May Be Time to Buy CrowdStrike Stock Heading Into EarningsCan IBM’s Q1 Earnings Spark a Breakout for the Stock? This page (NASDAQ:TLSI) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
